CD133 expression in chemo-resistant Ewing sarcoma cells - Wikidata - wikimedia - TriplyDB

CD133 expression in chemo-resistant Ewing sarcoma cells

CD133 expression in chemo-resistant Ewing sarcoma cells

http://www.wikidata.org/entity/Q33546702

about

Therapeutic strategies targeting cancer stem cells FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways Peripheral blood mononuclear CD133 mRNA levels correlates with response to treatment in patients with gastrointestinal stromal tumors An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species.Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential The first European interdisciplinary ewing sarcoma research summit Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group.MicroRNAs in Ewing Sarcoma.The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor.MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro.Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.Role of cancer stem cells in spine tumors: review of current literature.Sarcoma stem cells: do we know what we are looking for?CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy.Cancer stem cells in pediatric sarcomas.Therapy resistance mechanisms in Ewing's sarcoma family tumors.Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors.Role of Pericellular Matrix in the Regulation of Cancer Stemness.Differential remodeling of cadherins and intermediate cytoskeletal filaments influence microenvironment of solid and ascitic sarcoma.Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.Cancer Stem Cells and Pediatric Solid Tumors.Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling.Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas.miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor.A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas.

P2860

Q26781398-3985FDF7-A894-41C3-86B6-21E325DA3FDB Q28076296-FE7A15F2-479D-44A5-9424-4352B2DBB1F2 Q31110927-758C68ED-44E5-422D-818B-D644D42DF97C Q33275167-3BDCF646-AD58-4CC7-AD26-B4FECF312109 Q33750221-DCF08F43-CDA2-427F-8237-49FA3769E639 Q33908271-5B6A4D55-268A-42BC-9DF8-E228222CD083 Q33997274-5567BD4B-5744-49E3-B6F9-49A378C36F7F Q34226841-5BCBB2E8-48A6-4E2E-A51D-697882ABC313 Q34354781-24DB181A-208C-41E6-BE54-E85A4CF4518D Q35424191-E69826CD-72E6-46C0-AB75-ABA3306A3B81 Q35958012-B3B7983F-F4F1-4C8A-B7D8-D614F491779E Q35993560-50314C2A-8D85-4DF7-9F8E-D1C06670E451 Q36334761-388CEFDB-7A8B-4E25-BEE8-5CCCB2CF140D Q36545600-EB37F424-7E8D-4CA5-BC3F-FBCD360D3FDF Q36660550-855C660F-DF4E-4574-A0FB-ECF80C5B970E Q36700671-813CB19B-2384-4E22-BDD6-9685AEA34C3F Q36722134-1C8F0F34-25BA-4BA6-97E2-C9D78FF2989C Q37043780-5197C4D5-9E60-4A59-8ECD-E3C159DE5B57 Q37325197-35F8C4EE-CF06-4DA5-96FF-7F6C7020B7BE Q37372163-1EDC09BC-841E-4D13-8E38-760221FCAD9A Q37376411-BD7567BA-CB62-4D68-A951-5CEA84626394 Q37993701-549394E7-0AB1-4949-9D25-F7A325E33DE3 Q38015339-1809B604-C8B5-4F2F-93FA-18EDA9920A8F Q38035206-1B7A1B02-AB57-4F64-8B28-967F69A2EFAF Q38113988-0987B8D7-BC9F-419B-A4E0-1FF570713165 Q38118769-EF9515C4-33B5-4DBE-BA3A-C2C86D33780B Q38182423-C7D406A2-4A62-4BE6-B29F-22D33D6A56B0 Q38708102-6FE14D62-C05E-4EC7-9003-AC0D7F2B76FD Q38770102-9539DFF5-1844-4E0D-8446-1F6170B6A292 Q38937115-DD2FBD59-B626-487F-8D85-9485D71ADD2B Q39099804-31C954C4-B81D-4055-9270-5E2BC2E32013 Q39120248-2209E220-9B36-4B0D-BF5B-39E4494EBB3A Q39465605-3FA7DCAF-B532-4408-8BD3-C9B189E254AE Q39773200-A599CD6D-051F-4EC4-B864-C8E36BC49596 Q39823354-27094DCC-FE03-4F13-AA77-306C88B83237 Q39835483-2F1D8169-6B4A-48F3-8062-82C008ACD342 Q40695629-181B6F92-6F42-4E11-9E29-D3603EF6EF92 Q41051759-98DAD14A-D050-4467-B6AF-51C86FC1E9AE Q42269157-46353961-07C8-46BD-92F1-91021922628A Q50056834-C5A74CCF-68E1-49EB-8C33-17933854C889

P2860

CD133 expression in chemo-resistant Ewing sarcoma cells

http://www.wikidata.org/entity/Q33546702

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CD133 expression in chemo-resistant Ewing sarcoma cells

@ast

CD133 expression in chemo-resistant Ewing sarcoma cells

@en

CD133 expression in chemo-resistant Ewing sarcoma cells.

@nl

type

label

CD133 expression in chemo-resistant Ewing sarcoma cells

@ast

CD133 expression in chemo-resistant Ewing sarcoma cells

@en

CD133 expression in chemo-resistant Ewing sarcoma cells.

@nl

prefLabel

CD133 expression in chemo-resistant Ewing sarcoma cells

@ast

CD133 expression in chemo-resistant Ewing sarcoma cells

@en

CD133 expression in chemo-resistant Ewing sarcoma cells.

@nl

P1433

Q33546702-EE1262E4-FC09-4D9A-B899-4B562EB6EE8A

P1476

Q33546702-F6E01C76-3FF0-461D-844D-D5501E06274E

P2093

Q33546702-6A6BB565-B485-4301-960B-00C6EA4397AA

Q33546702-A86EDE62-F984-4212-AA1D-5AC955E5CC94

Q33546702-AFED6D4E-2D94-436B-83F8-193517DC5296

Q33546702-C27FFCB0-006C-44C2-9E12-203C8F2D19F5

Q33546702-C28A85AD-2936-45A1-88D9-058E0EF45A8D

Q33546702-D3195BEE-46AB-4A34-A3B4-556C91EB9DB3

Q33546702-E33CFFE9-1EB5-44E7-90BF-6CA87AE7A694

Q33546702-FFF93459-04DF-40CC-AF4B-B4403D0D48C9

P2860

Q33546702-0D0B87F3-1603-44BC-AB00-7319129F9D1F

Q33546702-12A04761-004D-4AF4-900A-CE3805FEFC01

Q33546702-14285DFD-FCA3-4457-AD20-FB88F20FEC9B

Q33546702-17381D6B-7AE8-4281-B238-CC336573CC8F

Q33546702-1CA777E2-0E70-478B-931B-062089286791

Q33546702-26008E66-57C1-4844-BBC2-D4EADB335472

Q33546702-26F1DDE3-3BB6-44E7-A03B-63146022344E

Q33546702-3BA6A1CB-136A-4BF5-B04C-AF911294F7F8

Q33546702-400AB491-EE2D-49A6-A570-999D7E81B69E

Q33546702-42CA7CF9-72A3-49BA-91A5-BAAAD7D1E293

P2888

Q33546702-7A13901D-1FE0-46A6-8294-CFF57D98E070

P304

Q33546702-C97D7C22-953E-4290-902F-9B7916BBEB2F

P31

Q33546702-6A6CC972-7F8D-4B69-8E1C-9E87A353A867

P356

Q33546702-3ADBA95A-A7E5-4BC3-A5FF-D5359E7D4EC9

P407

Q33546702-F63ABD03-890F-47CE-8079-81BAEEA5690E

P478

Q33546702-BD22C99B-9A77-4D71-9759-042931277AD0

P50

Q33546702-11260F8E-D8EF-4E7D-B7D1-0AB9EFEAFC8A

P577

Q33546702-DC0FA9E4-642A-4E86-847E-93619342EE08

P5875

Q33546702-E60D041A-D072-446A-AC92-F77E09334A75

P6179

Q33546702-6E88846E-AA85-4F5B-A6DA-B245CCCBCDFF

P698

Q33546702-41BA0B69-8F0C-4FC5-A686-0D5CAD6FA1C1

P932

Q33546702-5AA868D0-C891-4764-AFB8-74E9AD187901

P356

1471-2407-10-116

P1433

P1476

CD133 expression in chemo-resistant Ewing sarcoma cells

@en

P2093

Christine Cao

http://www.w3.org/2001/XMLSchema#string

Darren Russell

http://www.w3.org/2001/XMLSchema#string

Dorothea Douglas

http://www.w3.org/2001/XMLSchema#string

Elizabeth R Lawlor

http://www.w3.org/2001/XMLSchema#string

Long Hung

http://www.w3.org/2001/XMLSchema#string

Timothy J Triche

http://www.w3.org/2001/XMLSchema#string

Xiaohua Jiang

http://www.w3.org/2001/XMLSchema#string

Ynnez Gwye

http://www.w3.org/2001/XMLSchema#string

P2860

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Efficient tumour formation by single human melanoma cells

BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

Prospective identification of tumorigenic breast cancer cells

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Identification of human brain tumour initiating cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

AC133, a novel marker for human hematopoietic stem and progenitor cells

P2888

1471-2407-10-116

P304

116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-116

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42608877

http://www.w3.org/2001/XMLSchema#string

P6179

1032569982

http://www.w3.org/2001/XMLSchema#string

P698

20346143

http://www.w3.org/2001/XMLSchema#string

P932

2851692

http://www.w3.org/2001/XMLSchema#string